Mixed Results With RT Plus Short-Term ADT in Intermediate-Risk Prostate Cancer

(MedPage Today) -- CHICAGO--Adding a short course of androgen deprivation therapy (ADT) to dose-escalated radiotherapy (RT) led to a mixed bag of outcomes in intermediate-risk prostate cancer, according to a large randomized trial.
The addition...